Trial to Evaluate the Safety and Immunogenicity of Multivalent Pneumococcal Vaccines in Japanese Adults 18 to 49 Years of Age



Status:Active, not recruiting
Conditions:Pneumonia, Infectious Disease
Therapuetic Areas:Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases
Healthy:No
Age Range:18 - 49
Updated:3/29/2019
Start Date:August 29, 2018
End Date:March 28, 2019

Use our guide to learn which trials are right for you!

A PHASE 1B, RANDOMIZED, CONTROLLED, DOUBLE-BLIND TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF MULTIVALENT PNEUMOCOCCAL CONJUGATE VACCINES IN HEALTHY JAPANESE ADULTS 18 TO 49 YEARS OF AGE

This Phase 1b will describe the safety and immunogenicity of 2 multivalent pneumococcal
conjugate vaccine formulations in healthy Japanese adults in the United States.


Inclusion Criteria:

- Male or female Japanese subjects 18 to 49 years of age, defined as Japanese born in
Japan, with both parents and 4 grandparents who wer born in Japan (family tree by
history), and who have not lived outside of Japan for more than 5 years total
(confirmed by passport or interview)

Exclusion Criteria:

- Participation in other studies involving investigational drug(s), investigational
vaccines, or investigational medical devised within 28 days prior to study entry
and/or during study participation. Participation in purely observational studies is
acceptable.
We found this trial at
4
sites
Garden Grove, California 92845
?
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Eatontown, New Jersey 07724
?
mi
from
Eatontown, NJ
Click here to add this to my saved trials
Honolulu, Hawaii 96814
?
mi
from
Honolulu, HI
Click here to add this to my saved trials
Long Beach, California 90806
?
mi
from
Long Beach, CA
Click here to add this to my saved trials